Publications

Vyas, Madhusudan., & Beasley, Charles. (2024). Using Radiation for Diagnosis and Cancer Treatment. NewZealand, Good Clinical.

Vyas, Madhusudan. (2024). Advancing inclusive prostate cancer care: Extending the reach of mobile PSMA-PET/CT to local, regional, and remote communities across Aotearoa/New Zealand. ANZSNM-2024, Christchurch.

Vyas, Madhusudan., Chandershekar, Rudresh., Mafi, Nick., Fagan, Jessica., & Henderson, Andrew. (2023). Yttrium-90 Based bremsstrahlung Imaging with a solid state detector Gamma camera: A first imaging experience with GE-NM CT 850. Journal of Nuclear Medicine, SNMMI-2023 (Vol. 64).

Vyas, Madhusudan., & Glassenbury, Angus. (2023). Workflow experience: Comparative analysis of analog and digital PET. Journal of Nuclear Medicine, SNMMI-2023 (Vol. 64).

Vyas, Madhusudan., & Joseph, Rosane. (2023). The role of the Nursing care in Theranostic: a reflective qualitative review. Journal of Nuclear Medicine, SNMMI-2023 (Vol. 64).

Vyas, Madhusudan., & Glassunburry, Angus. (2023). FAPI: Still more question to be answered-A review-based analysis. Journal of Nuclear Medicine, SNMMI-2023 (Vol. 64).

Vyas, M., & Glassunburry, Angus. (2023). Workflow experience: Comparative analysis of analog and digital PET. Journal of Nuclear Medicine, SNMMI-2023 (Vol. 64).

Vyas, Madhusudan. (2023). Nuclear Medicine Educator's Repository:An Update. SNMMI-2023, Chicago, USA.

Vyas, Madhusudan., & Leslie, Stephen. (2023). Nuclear Medicine Applications in Prostate Cancer. Statepearls (Vol. PMID: 37276321).

Vyas, Madhusudan., & Sharma, Sandeep. (2023). An overview of Radiochemical Identity and Radiochemical purity of 18F-FDG and factor affecting the RCP. Journal of Nuclear Medicine, SNMMI-2023 (Vol. 64).

Panting, Andrew., Fagan, Jessica., Lim, Remy., & Vyas, Madhusudan. (2023). [89Zr]Zr-Girentuximab PET/CT for the targeted diagnosis of clear cell renal cell carcinoma (ccRCC). ANZSNM-NZ Symposium-2023, Auckland.

Edmond, Stephen., Davidson, Jenny., & Vyas, Madhusudan. (2023). Imaging pathway of a pediatric patient with SDHB-deficient paraganglioma. Journal of Nuclear Medicine Technology (Vol. vol.72).

Buttfield, M., Kashyap, p., Lim, R., & Vyas, M. (2023). Improved practitioner and patient outcomes with uAI Hyper DPR vs OSEM reconstruction on the United uMI780 system. European congress of Radiology (ECR)-2023, Vienna, Austria.

Vyas, Madhusudan., & Wolf, Erik. (2022). Radiology Technology CT: Specialty Review and Self-Assessment. USA, StatPearls Publishing LLC; 6th edition (October 27, 2016) (Vol. 6th).

Vyas, Madhusudan., Fagan, Jessica., Joseph, Rosane., Henderson, Andrew Millar., & Rowling, Abby. (2022). A Tale of Serendipity from Misadministration. EANM-2022, Barcelona, Spain (Vol. 49 (Suppl 1): S1-S751).

Vyas, Madhusudan. (2022). A first NZ Study Looked at the Role of Lutetium-177-PSMA I & T in the Progression of mCRPC. Auckland/Northland Branch NZIMRT, Auckland University Medical School, Auckland.

Sharma, Sandeep., Vyas, Madhusudan., Kar, B.N., Soni, P.S., Gowda, K.B., & M, Kavirasu. (2022). Developed and validated script for 18F - PSMA -1007 Synthesis in IBA - Synthera version-01. SNMMI-2022 (Vol. Vol. 63, Issue supplement 2).

Sharma, Sandeep., Vyas, Madhusudan., Chaskar, Satish., & Kar, B.N. (2022). Developed a model for remote installation of Radiochemistry Synthesiser; Trasis - AllInOne: One Step forward to beat Covid-19 pandemic. SNMMI-2022, Vancouver, Canada (Vol. Vol. 63, Issue supplement 2).

Sharma, Sandeep., Vyas, Madhusudan., Sateesh, D., BC Kumar, Naveen., Gangadhara, v., Singh, Swatantra., Behra K., Sangram., & Kar, B.N. (2022). 18F-FDG Production and Quality Control (QC) Parameters Comparison in three different Automatic Synthesis Modules: An Experience of Commercial Centre. SNMMI-2022, Vancouver, Canada (Vol. Vol. 63, Issue supplement 2).

Vyas, Madhusudan., Davidson, Jennifer., & Joseph, Rosane. (2022). NET imaging:Past,present and Future. SNMMI-2022, Vancouver, Canada (Vol. Vol. 63, Issue supplement 2).

Vyas, Madhusudan., Lim, Remy., Garrett, Nick., & Fagan, Jessica. (2022). A first study looked at the role of lutetium-177-PSMA-I&T in the progression of metastatic castrate-resistant prostate cancer (mCRPC). SNMMI-2022 Hybrid anual conference, Vancouver, Canada (Vol. Vol. 63, Issue supplement 2).

Vyas, Madhusudan., Fagan, Jessica., Lim, Remy., & Chandershekar, Rudresh. (2022). Stability matters: Radiochemical stability of therapeutic radiopharmaceutical of 177Lu-PSMA-I&T. Journal of Nuclear Medicine Technology (Vol. 50).

Vyas, Madhusudan., Wolf, Erik., & Faridi, David. (2022). Radiology Tech Nuclear Medicine: Board and Certification Review. USA, StatPearls Publishing, LLC; 6th edition (February 21, 2018) (Vol. 6th).

Vyas, Madhusudan. (2022). Positive treatment outcomes of erratic Liver metastases in end-stage metastatic prostate cancer with Radioligand therapy of 177Lu-PSMA-I&T. EANM-2022, Barcelona, Spain (Vol. 49 (Suppl 1): S1-S751).

Vyas, Madhusudan., Singh, Vikramjeet., & Beck, Ayesha. (2022). Radiology Tech: Board and Certification Review. USA, StatPearls Publishing, LLC; 6th edition (21 August 2015) (Vol. 6th).

Vyas, M. (2021). Lutetium-177: a flexible radionuclide therapeutic options. SNMMI-2021 Virtual conference, Virtual conference (Vol. 62).

Henderson, Andrew Millar., Barden, Maddison., Painting, Andrew., & Vyas, Madhusudan. (2021). Covid-19 vaccine related uptake in Ga-68 DOTATATE scan. EURORAD (Vol. ISSN: 1563-4086).

Vyas, Madhusudan., & Tafti, Dawood. (2021). Nuclear Medicine Quality Assurance. USA, Statpearl.com.

Vyas, Madhusudan., Lim, Remy., Fagan, Jessica., & Chandrashekar, Rudresh. (2021). Stability matters. National ITP Research Symposium 2021, Wellington, New Zealand.

Vyas, Madhusudan., Garett, Nick., Lim, Remy., & Fagan, Jessica. (2021). A first New Zealand study looked at the role of lutetium-177-P SMA I &T in the progression of metastatic castrate-resistant prostate cancer. National ITP Research Symposium 2021, Wellington, New Zealand.

Vyas, Madhusudan., Fagan, Jessica., Lim, Remy., & Garett, Nick. (2020). Lutetium-177-PSMA I&T for progressing metastatic castrate-resistant prostate cancer: A single NZ centre experience. New Zealand Society for Oncology-2020, Auckland, New Zealand.

Vyas, Madhusudan. (2020). Analysis of the Positive Impacts of the Lu177-PSMA Treatment for metastatic castration-resistant prostate cancer (mCRPC). DOI:10.26044/ecr2020/C-00307. ECR-2020, Vienna.

Vyas, M., Aziz, J., & Thorogood, J. (2020). A journey on an unknown path: the unexpected experience of online simulation-based teaching to medical imaging students under COVID-19 lockdown. Simulation-Based Education in Radiography/MRS: A Response to COVID-19, Online organized by Universit of Liverpool, UK.

Wu, L., Thorogood, J., & Vyas, M. (2020). Application of Quantitative CT and Artificial Intelligence in Assessment of Chronic Obstructive Pulmonary Disease ( COPD).DOI :10.26044/ecr2020/C-02475. European Congress of Radiology (ECR)-2020, Vienna.

Davidson, J., Sundarajan, J., & Vyas, . (2019). NET Imaging: Past, present and future. NZIMRT/ANZSNM-2019, Rotorua.

Vyas, M. (2019). Nuclear Reactor to the hot lab: An overview of the Radiochemistry of Lu-177. NZIMRT/ANZSNM-2019, Rotorua.

Vyas, M., Fagan, J., & Shaikh, S. (2019). A ray of hope patients with metastatic castration-resistant prostate cancer (mCRPC) sufferers: Positive impacts of the Lu177- PSMA Treatment in the advanced stage of Prostate cancer. NZIMRT/ANZSNM-2019, Rotorua.

Vyas, M. (2019). A Ray of Hope in Pessimism? Quality of life evaluation during novel therapy for metastatic castration-resistant prostate cancer (mCRPC). AUT University, Auckland, NZ, South campus Aut University, Auckland.

Wu, L., Thorogood, J., & Vyas, M. (2019). Implication of Quantitative CT and Artifical Intelligence in COPD. The 4th Asian Congress of Thoracic Imaging Conference (ACTI), Shanghai, China.

Uche, C.Z., Vyas, M., Thorogood, J., Round, W.H., & Cree, M. (2019). Monte Carlo simulation of the Compton camera for nuclear medical imaging. EPSM 2018, Engineering and Physical Sciences in Medicine 29-31 October 2018, Adelaide Convention Centre, Adelaide, Australia.

Vyas, M., & Sharma, S. (2019). Comparative analysis of 68Ga,18F and 99mTc labelled with Prostate Specific Membrane Antigen (PSMA). European Congress of Radiology (ECR) -2019, Vienna, Austria.

Vyas, M., & Shaikh, S. (2019). Lutetium-177: a game changer Theranostic agent. European Congress of Radiology (ECR)-2019, Vienna, Austria.

Vyas, M., & Fagan, J. (2019). Black Hole Resemblance with Medical Imaging: A Beautiful Coincidence. NZIMRT/ANZSNM-2019, Rotorua.

Vyas, Madhusudan. (2018). Lu-177: A Game-changer. ANZSNM- Annual Branch Meeting-2018, Invercargill,New Zealand.

Uche, C., Vyas, M., & Thorogood, J. (2018). Monte Carlo simulation of the Compton camera for nuclear medical imaging. EPSM-2018, Adelaide, Australia.

Vyas, Madhusudan. (2015). Role of Nuclear Medicine in NET imaging. NZIMRT - Annual Day, Wellington.

Vyas, Madhusudan. (2015). The Somatostatin Receptor Imaging: A Technical Overview. ANZSNM- Annual Branch Meeting-2015, Auckland-2015.

Vyas, M. (2015, September). Protein Losing Enteropathy (PLE) diagnosed in a patient with congenital generalised lymphedema using 99mTc-HSA (Human Serum Albumin) Scintigraphy. Oral presentation for Radpharm Award competition at the ANZSNM - Annual Branch Meeting, Auckland.

Gupta, K., Krishna, B. A., Singh, N., & Vyas, M. (2013). Usefulness of fluorodeoxyglucose-positron emission tomography-computed tomography in patients with gastrointestinal lymphoma. Indian Journal of Nuclear Medicine (Vol. Indian J Nucl Med. 2013 Dec; 28(Suppl 1): S6-S10.).

Singh, N., Krishna, B. A., Vyas, M., Venkatesh, M., Banerjee, S., Das, T., Nair, K. V .V., & Sudipta (2011). Lutetium DOTATATE whole body scans: a novel approach for evaluation of neuroendocrine tumors. Indian Journal of Nuclear Medicine (Vol. v. 26(3)).